scholarly article | Q13442814 |
P2093 | author name string | Jie Xu | |
Jiao Li | |||
Yuxin Yang | |||
Tianming Li | |||
Xiaonan Li | |||
Xin Gui | |||
Yanan Lu | |||
Zhuojia Lin | |||
Dongdong Lu | |||
Hu Pu | |||
Song Jia | |||
Xiaoru Xin | |||
Mengying Wu | |||
Jiahui An | |||
Qidi Zheng | |||
P2860 | cites work | Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels | Q24309167 |
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma | Q24630639 | ||
Association of single nucleotide polymorphisms in PIM-1 gene with the risk of Korean lung cancer | Q24645195 | ||
KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells | Q27007679 | ||
Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells | Q28533855 | ||
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity | Q33591747 | ||
HP1α mediates defective heterochromatin repair and accelerates senescence in Zmpste24-deficient cells | Q33728360 | ||
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors | Q34358720 | ||
YY1-MIR372-SQSTM1 regulatory axis in autophagy | Q34373008 | ||
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. | Q34494886 | ||
SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability | Q35188529 | ||
A chromatin code for alternative splicing involving a putative association between CTCF and HP1α proteins | Q35620759 | ||
Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas | Q35685531 | ||
miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo | Q35742465 | ||
Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer. | Q35854027 | ||
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation | Q36275644 | ||
Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway | Q36338868 | ||
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma | Q36373524 | ||
TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing | Q36543721 | ||
Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair | Q36905850 | ||
ETS transcription factor ERG cooperates with histone demethylase KDM4A. | Q36908878 | ||
MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC). | Q36916304 | ||
Epigenomics meets splicing through the TETs and CTCF. | Q37068074 | ||
Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells | Q37095651 | ||
Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I. | Q37099828 | ||
TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.). | Q37181402 | ||
Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs | Q37352034 | ||
DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells | Q37433340 | ||
Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. | Q37480033 | ||
A miR-372/let-7 Axis Regulates Human Germ Versus Somatic Cell Fates | Q37486199 | ||
The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability. | Q37505139 | ||
Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR | Q37687017 | ||
PIM kinases as therapeutic targets against advanced melanoma | Q37688157 | ||
Why Target PIM1 for Cancer Diagnosis and Treatment? | Q37797472 | ||
The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression | Q38161942 | ||
The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways | Q38789657 | ||
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. | Q38790387 | ||
Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression | Q38813869 | ||
CTCF negatively regulates HOXA10 expression in breast cancer cells. | Q38826909 | ||
SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A. | Q38905893 | ||
HP1 is involved in regulating the global impact of DNA methylation on alternative splicing | Q38907065 | ||
Elucidating the roles of miR-372 in cell proliferation and apoptosis of nasopharyngeal carcinoma TW01 cells. | Q38952346 | ||
miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. | Q38962553 | ||
Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases | Q39120599 | ||
Caudatin induces cell apoptosis in gastric cancer cells through modulation of Wnt/β-catenin signaling | Q39147372 | ||
A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy. | Q39203783 | ||
Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma | Q39215878 | ||
Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines | Q39808895 | ||
Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma | Q40483674 | ||
microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFκB signaling in human gastric carcinoma cells | Q45836713 | ||
JMJD2A predicts prognosis and regulates cell growth in human gastric cancer | Q87823319 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver cancer | Q623031 |
P304 | page(s) | 49093-49109 | |
P577 | publication date | 2017-04-13 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372. | |
P478 | volume | 8 |
Search more.